521 related articles for article (PubMed ID: 18577894)
41. Novel intrapleural therapies for malignant diseases.
Haas AR; Sterman DH
Respiration; 2012; 83(4):277-92. PubMed ID: 22456231
[TBL] [Abstract][Full Text] [Related]
42. Hyperthermia and mafosfamide in a human-derived malignant pleural mesothelioma cell line.
Ehlers EM; Kühnel W; Wiedemann GJ
J Cancer Res Clin Oncol; 2002 Feb; 128(2):65-72. PubMed ID: 11862475
[TBL] [Abstract][Full Text] [Related]
43. Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?
Rusch VW
J Clin Oncol; 2003 Jul; 21(14):2629-30. PubMed ID: 12860935
[No Abstract] [Full Text] [Related]
44. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
[TBL] [Abstract][Full Text] [Related]
45. [Diffuse malignant pleural mesothelioma].
Katsuragi N; Shiraishi Y; Kita H; Toishi M; Miyasaka Y; Tanaka S
Kyobu Geka; 2007 Jan; 60(1):35-9. PubMed ID: 17249536
[TBL] [Abstract][Full Text] [Related]
46. Advances in the biology of malignant pleural mesothelioma.
Zucali PA; Ceresoli GL; De Vincenzo F; Simonelli M; Lorenzi E; Gianoncelli L; Santoro A
Cancer Treat Rev; 2011 Nov; 37(7):543-58. PubMed ID: 21288646
[TBL] [Abstract][Full Text] [Related]
47. Radical surgery for malignant pleural mesothelioma: results and prognosis.
Okada M; Mimura T; Ohbayashi C; Sakuma T; Soejima T; Tsubota N
Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):102-6. PubMed ID: 18048410
[TBL] [Abstract][Full Text] [Related]
48. Local recurrence of tumor at sites of intervention in malignant pleural mesothelioma.
Metintas M; Ak G; Parspour S; Yildirim H; Erginel S; Alatas F; Batirel HF; Sivrikoz C; Metintas S; Dundar E
Lung Cancer; 2008 Aug; 61(2):255-61. PubMed ID: 18304688
[TBL] [Abstract][Full Text] [Related]
49. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy.
Nakas A; Trousse DS; Martin-Ucar AE; Waller DA
Eur J Cardiothorac Surg; 2008 Oct; 34(4):886-91. PubMed ID: 18656373
[TBL] [Abstract][Full Text] [Related]
50. [Extrapleural pneumonectomy of malignant pleural mesothelioma].
Yoon HE; Nonaka K; Fukuhara K; Ueshima H; Sugiura T; Kaneda H; Shimamoto S; Imakita M; Iwase K
Kyobu Geka; 2004 Oct; 57(11):1011-5. PubMed ID: 15510813
[TBL] [Abstract][Full Text] [Related]
51. [Surgery and hyperthermic pleural perfusion--a new approach for malignancies with pleural involvement].
Yellin A; Simansky D; Paley M; Friedman H; Teperberg M; Refaely Y
Harefuah; 2002 Apr; 141(4):335-9, 411. PubMed ID: 12017884
[TBL] [Abstract][Full Text] [Related]
52. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
Flores RM; Routledge T; Seshan VE; Dycoco J; Zakowski M; Hirth Y; Rusch VW
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):605-10. PubMed ID: 18805259
[TBL] [Abstract][Full Text] [Related]
53. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.
Hiraki A; Aoe K; Murakami T; Nakamura Y; Yamazaki K; Sueoka N; Taguchi K; Kamei T; Maeda T; Takeyama H; Kishimoto T; Nishimura M; Sugi K
Oncol Rep; 2005 Aug; 14(2):357-62. PubMed ID: 16012715
[TBL] [Abstract][Full Text] [Related]
54. A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results.
Pass HI; Brewer GJ; Dick R; Carbone M; Merajver S
Ann Thorac Surg; 2008 Aug; 86(2):383-9; discussion 390. PubMed ID: 18640301
[TBL] [Abstract][Full Text] [Related]
55. High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma.
Halme M; Knuuttila A; Vehmas T; Tammilehto L; Mäntylä M; Salo J; Mattson K
Br J Cancer; 1999 Aug; 80(11):1781-5. PubMed ID: 10468296
[TBL] [Abstract][Full Text] [Related]
56. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases.
Richards WG; Godleski JJ; Yeap BY; Corson JM; Chirieac LR; Zellos L; Mujoomdar A; Jaklitsch MT; Bueno R; Sugarbaker DJ
Cancer; 2010 Mar; 116(6):1510-7. PubMed ID: 20108310
[TBL] [Abstract][Full Text] [Related]
57. Adjuvant therapy for malignant pleural mesothelioma.
Keller SM
Chest Surg Clin N Am; 1994 Feb; 4(1):127-35. PubMed ID: 8055277
[TBL] [Abstract][Full Text] [Related]
58. [Malignant mesothelioma of the pleura].
Erika V; Zoltán S; Miklós Z; Judit A; Akos L; Kálmán K
Orv Hetil; 1996 Feb; 137(5):233-8. PubMed ID: 8882441
[TBL] [Abstract][Full Text] [Related]
59. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma.
Anraku M; Cunningham KS; Yun Z; Tsao MS; Zhang L; Keshavjee S; Johnston MR; de Perrot M
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):823-9. PubMed ID: 18374762
[TBL] [Abstract][Full Text] [Related]
60. [Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma].
Bakhshandeh A; Bruns I; Eberhardt K; Wiedemann GJ
Dtsch Med Wochenschr; 2000 Mar; 125(11):317-9. PubMed ID: 10761473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
